Home > PS Ratio > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 9.56.

Share Price ₹1,868.9Apr 19,2024
Market Cap ₹31,658.3 Cr
Sales-TTM₹3,311.4 CrTTM-Consolidated Results
Price/Sales9.56xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of GLAXOSMITHKLINE PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of GLAXOSMITHKLINE PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹31,658.3 Cr] as on Apr 19,2024

(/) Sales [ ₹3,311.4 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 9.56x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for GLAXOSMITHKLINE PHARMACEUTICALS , the investors are currently willing to pay '9.56 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of GLAXOSMITHKLINE PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of GLAXOSMITHKLINE PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of GLAXOSMITHKLINE PHARMACEUTICALS


PS Ratio Performance Analysis for GLAXOSMITHKLINE PHARMACEUTICALS

- GLAXOSMITHKLINE PHARMACEUTICALS 's latest p/e ratio is 9.56x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 7.48x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's operated at median p/e ratio of 7.04x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 8.59x.

- GLAXOSMITHKLINE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 6.54x.


How does GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
GLAXOSMITHKLINE PHARMACEUTICALS 3,311.49.5631,658.3
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.70365,311.0
CIPLA LTD25,350.24.28108,623.0
DR REDDYS LABORATORIES LTD27,212.53.6499,134.3
ZYDUS LIFESCIENCES LTD19,024.24.8892,794.9
DIVIS LABORATORIES LTD7,492.813.0097,408.4
MANKIND PHARMA LTD9,946.39.4193,565.4
TORRENT PHARMACEUTICALS LTD10,474.08.2085,858.5
LUPIN LTD19,480.13.6270,506.8
AUROBINDO PHARMA LTD27,894.72.2863,697.4
ABBOTT INDIA LTD5,753.49.6555,528.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAXOSMITHKLINE PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.28x
Max industry PS 13.00x
Median industry PS 7.70x
Average industry PS 6.93x



You may also like the below Video Courses